CoChat
Sign Up
Cited by 186Systemic Lupus Erythematosus ResearchHormonal and reproductive studiesAdrenal Hormones and Disorders

Influence of Testosterone Therapy on Clinical and Immunological Features of Autoimmune Diseases Associated with Klinefelter’s Syndrome

BIZZARRO, A., VALENTINI, G., MARTINO, G. DI, DAPONTE, A., DE BELLIS, A., IACONO, G.·1987·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jcem-64-1-32
Open this paper in CoChat — free account

Abstract

To examine the role of sex steroid hormones in the development of autoimmune diseases, we studied five patients with Klinefelter's syndrome associated with autoimmune disease, three of whom had Sjögren's syndrome (SS) and two of whom had systemic lupus erythematosus (SLE). Serum testosterone (T) and LH levels, antinuclear antibodies (ANA) and rheumatoid factor (RF) titers, erythrocyte sedimentation rate (ESR), hemolytic complement (CH50) levels, and peripheral T lymphocyte subsets (OKT3+, OKT4+, and OKT8+) were measured before treatment, after 60 days of placebo treatment, and after 60 days of oral T undecanoate (TU) treatment. Before treatment and after placebo, with respect to normal men, the patients had lower serum T and higher LH levels, lower percentages and absolute values of OKT3+ (total T lymphocytes) and OKT8+ (suppressor/cytotoxic T lymphocytes) cells, and, consequently, an increased OKT4/OKT8 ratio. Hemolytic complement (CH50) in serum was below normal in the two patients with SLE, while it was normal in the patients with SS. The ESR was above normal in all patients, and all had high titers of ANA and RF. After TU therapy, serum T levels increased and LH levels decreased, but not to normal. OKT3+ and OKT8+ cells and the OKT4/OKT8 ratio became normal, and RF and ANA titers decreased. The CH50 level did not change in the SS patients, while it increased to normal in the two patients with SLE. The ESR decreased in all patients during therapy. Furthermore, after TU therapy, both the SS and SLE patients had a clinical remission of their autoimmune disease. Our results indicate a therapeutic effect of T on autoimmune diseases in patients with hypogonadism and Klinefelter's syndrome.

Integrity signals

Registry

Crossref · 10.1210/jcem-64-1-32

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Case reports and randomised controlled trials of androgen therapy in inflammatory diseases such as rheumatoid arthritis or systemic lupus erythematosus have found androgens improve clinical status and reduce inflammatory markers.

    “There are several case reports and randomised controlled trials of androgen therapy in patients with inflammatory disease such as rheumatoid arthritis or systemic lupus erythematosus in which androgens have been found to improve clinical status and reduce inflammatory markers.[33][34][35]”

    From Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life (2004) · cites this paper as [34]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
BIZZARRO, A., VALENTINI, G., MARTINO, G. D., DAPONTE, A., DE BELLIS, A., & IACONO, G.
Affiliations
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
ORCID
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
1987-01
Volume
64
Issue
1
Pages
32-36
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
DOI
10.1210/jcem-64-1-32
OpenAlex
W1963558638
Cited by
186
References
8
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2021: 6 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 9 · 2013: 5 · 2012: 1
FWCI
1.98
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
testosterone replacement therapy, Klinefelter syndrome, autoimmune disease, Sjögren's syndrome, systemic lupus erythematosus, sex hormones, hypogonadism, T cell subsets, OKT4/OKT8 ratio, antinuclear antibodies, rheumatoid factor, hemolytic complement, clinical remission, testosterone undecanoate
MeSH terms
Adult, Antibodies, Antinuclear, Autoimmune Diseases, Blood Sedimentation, Complement System Proteins, Follicle Stimulating Hormone, Humans, Klinefelter Syndrome, Luteinizing Hormone, Male, Rheumatoid Factor, T-Lymphocytes, Testosterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review